Value of GlutathioneS-Transferase π and the Oncogene Products c-Jun, c-Fos, c-H-Ras, and c-Myc as a Prognostic Indicator in Endometrial Carcinomas
- 31 March 1998
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 68 (3) , 280-287
- https://doi.org/10.1006/gyno.1998.4936
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Correlated Expression of Glutathione S‐Transferase‐π and c‐Jun or Other Oncogene Products in Human Squamous Cell Carcinomas of the Head and Neck: Relevance to Relapse after Radiation TherapyJapanese Journal of Cancer Research, 1997
- c‐jun oncogene expression in transitional cell carcinoma of the urinary bladderBritish Journal of Urology, 1994
- Analysis of c-fos, c-jun, c-erbB1, c-erbB2 and c-myc in primary lung carcinomas and their lymph node metastasesClinical & Experimental Metastasis, 1994
- Immunohistochemical Detection of the c-myc Oncogene Product in Normal, Hyperplastic and Carcinomatous EndometriumOncology, 1994
- Detection of human papillomavirus genome and analysis of expression of c-myc and Ha-ras oncogenes in invasive cervical carcinomasGynecologic Oncology, 1992
- Expression of c-jun, jun-B, and c-fos Proto-Oncogenes in Human Primary Melanocytes and Metastatic MelanomasJournal of Investigative Dermatology, 1991
- Oncogene expression in cervical intraepithelial neoplasia and invasive cancer of cervixThe Lancet, 1991
- Expression of ras oncogene product and EGF receptor in cervical squamous cell carcinomas and its relationship to lymph node involvementGynecologic Oncology, 1991
- Structure of the human genomic glutathione S-transferase-π geneGene, 1989
- Estrogen and progestin receptor levels as prognosticators for survival in endometrial cancerGynecologic Oncology, 1988